Published in Virology on May 01, 1988
Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med (1994) 2.87
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J Virol (2005) 2.17
The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol (2001) 1.80
Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins. J Virol (2006) 1.71
Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan. J Virol (2005) 1.56
Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol (2008) 1.39
Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito. J Virol (2008) 1.37
X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc Natl Acad Sci U S A (2011) 1.27
Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. J Virol (2007) 1.24
Cellular entry of lymphocytic choriomeningitis virus. J Virol (2007) 1.12
Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell. Mol Biol Cell (2007) 1.12
Mapping the landscape of the lymphocytic choriomeningitis virus stable signal peptide reveals novel functional domains. J Virol (2007) 1.09
Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses. J Virol (2010) 1.06
Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J Virol (2010) 1.03
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers. Virology (2007) 1.02
cDNA sequence analysis confirms that the etiologic agent of callitrichid hepatitis is lymphocytic choriomeningitis virus. J Virol (1995) 0.99
Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. J Virol (2007) 0.93
Role of the host cell's unfolded protein response in arenavirus infection. J Virol (2010) 0.93
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat Commun (2016) 0.90
Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242. Virology (2011) 0.89
Isolation of an arenavirus from a marmoset with callitrichid hepatitis and its serologic association with disease. J Virol (1991) 0.89
Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease. J Virol (2012) 0.89
Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan. Cell Microbiol (2012) 0.86
Glycosylation modulates arenavirus glycoprotein expression and function. Virology (2010) 0.86
Expression level of a pancreatic neo-antigen in beta cells determines degree of diabetes pathogenesis. J Autoimmun (2010) 0.84
Role of DC-SIGN in Lassa virus entry into human dendritic cells. J Virol (2013) 0.84
Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus. J Virol (2007) 0.84
Zymogen activation and subcellular activity of subtilisin kexin isozyme 1/site 1 protease. J Biol Chem (2014) 0.79
Arenavirus stable signal peptide is the keystone subunit for glycoprotein complex organization. MBio (2014) 0.79
The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain. Virology (2012) 0.78
Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan. Cell Microbiol (2012) 0.78
Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid. Antiviral Res (2013) 0.77
Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever. J Virol (2016) 0.77
Mechanism of Folding and Activation of Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P). J Biol Chem (2015) 0.75
A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease. J Virol (2015) 0.75
The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector Immunogenicity. J Virol (2015) 0.75
The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol (1980) 6.24
Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology (1981) 3.26
Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion. Virology (1982) 2.94
Coronavirus spike proteins in viral entry and pathogenesis. Virology (2001) 2.85
Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology (1984) 2.57
Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology (1987) 2.53
Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol (1986) 2.35
Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J Virol (1991) 2.16
Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol (1989) 2.08
A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol (2000) 2.04
Protein structure of lymphocytic choriomeningitis virus: evidence for a cell-associated precursor of the virion glycopeptides. Virology (1979) 2.00
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol (1986) 1.95
Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol (1997) 1.93
The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol (2000) 1.91
Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins. J Virol (1987) 1.87
Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol (1998) 1.83
The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol (2001) 1.80
Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology (1989) 1.79
The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2. J Virol (1985) 1.74
Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature (1982) 1.73
Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology (1986) 1.71
Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike. Virology (1994) 1.70
Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology (1984) 1.69
Protein-protein interactions in lymphocytic choriomeningitis virus. Virology (1991) 1.68
Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J Virol (1992) 1.66
Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment. J Virol (1985) 1.60
Western and dot immunoblotting analysis of viral antigens and antibodies: application to murine hepatitis virus. J Immunol Methods (1984) 1.58
Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus. Virology (1990) 1.58
Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death. Virology (1997) 1.57
Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J Virol (1990) 1.55
Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. Br Med Bull (1985) 1.52
Analysis of the genomic L RNA segment from lymphocytic choriomeningitis virus. Virology (1987) 1.43
Protein structure of lymphocytic choriomeningitis virus: identification of the virus structural and cell associated polypeptides. Virology (1978) 1.43
Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression. Virology (1989) 1.41
The reticuloendothelium as the target in a virus infection. Pichinde virus pathogenesis in two strains of hamsters. Lab Invest (1977) 1.41
Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection. J Virol (1991) 1.40
The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology (1992) 1.39
Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex. Virology (1995) 1.37
Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). Am J Pathol (1983) 1.37
Cell receptor-independent infection by a neurotropic murine coronavirus. Virology (1992) 1.31
Variation between strains of hamsters in the lethality of Pichinde virus infections. Infect Immun (1977) 1.28
Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol (1994) 1.25
Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection. J Immunol (1978) 1.24
Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways. Virology (1997) 1.24
Immuno-gold localization of prion filaments in scrapie-infected hamster brains. Lab Invest (1987) 1.22
Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J Virol (1997) 1.22
Perturbation of differentiated functions during viral infection in vivo. I. Relationship of lymphocytic choriomeningitis virus and host strains to growth hormone deficiency. Virology (1985) 1.21
Physicochemical properties of Marburg virus: evidence for three distinct virus strains and their relationship to Ebola virus. J Gen Virol (1988) 1.19
Serial passage of microglial SIV results in selection of homogeneous env quasispecies in the brain. Virology (1995) 1.18
Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo. Biochem Soc Trans (2007) 1.17
Protein analysis of defective interfering lymphocytic choriomeningitis virus and persistently infected cells. Virology (1979) 1.15
In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon. J Exp Med (1981) 1.13
Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci U S A (1999) 1.11
Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses. Nature (1980) 1.06
In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain. Proc Natl Acad Sci U S A (1988) 1.04
Antigenic variation among murine coronaviruses: evidence for polymorphism on the peplomer glycoprotein, E2. Virus Res (1985) 1.04
In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am J Pathol (2001) 1.04
Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells. J Virol (1997) 1.02
Viral induction of central nervous system innate immune responses. J Virol (2005) 1.02
Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system disease. Mol Med (1996) 0.99
Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol (1998) 0.98
Inhibition of nitric oxide synthase-2 reduces the severity of mouse hepatitis virus-induced demyelination: implications for NOS2/NO regulation of chemokine expression and inflammation. J Neurovirol (1999) 0.96
Pathogenesis of virus-induced demyelination. Adv Virus Res (1993) 0.95
Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice. Immunology (1987) 0.94
Properties and characterization of monoclonal antibodies to Tacaribe virus. J Gen Virol (1985) 0.93
Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection. J Immunol (1980) 0.93
Epitope-specific antibody response to murine hepatitis virus-4 (strain JHM). J Immunol (1985) 0.92
Antigens of Pichinde virus I. Relationship of soluble antigens derived from infected BHK-21 cells to the structural components of the virion. J Virol (1977) 0.92
Protein structure and expression among arenaviruses. Curr Top Microbiol Immunol (1987) 0.91
Teratogenic effects of neonatal arenavirus infection on the developing rat cerebellum are abrogated by passive immunotherapy. Virology (1993) 0.89
Isolation of an arenavirus from a marmoset with callitrichid hepatitis and its serologic association with disease. J Virol (1991) 0.89
In vivo and in vitro models of demyelinating diseases. V. Comparison of the assembly of mouse hepatitis virus, strain JHM, in two murine cell lines. Intervirology (1982) 0.89
Spike glycoprotein-mediated fusion in biliary glycoprotein-independent cell-associated spread of mouse hepatitis virus infection. Virology (1996) 0.88
A protein kinase activity in lymphocytic choriomeningitis virus and identification of the phosphorylated product using monoclonal antibody. Virology (1983) 0.87
Immunodominant T cell epitope from signal sequence. Science (1992) 0.87
Inhibition of Pichinde virus replication by actinomycin D. J Gen Virol (1976) 0.87
Dissecting the molecular anatomy of the nervous system: analysis of RNA and protein expression in whole body sections of laboratory animals. Brain Res (1986) 0.86
The CXC chemokines IP-10 and Mig are essential in host defense following infection with a neurotropic coronavirus. Adv Exp Med Biol (2001) 0.86
High efficiency immunoaffinity purification of anti-peptide antibodies on thiopropyl sepharose immunoadsorbants. Pept Res (1992) 0.85
Persistent dentate granule cell hyperexcitability after neonatal infection with lymphocytic choriomeningitis virus. J Neurosci (1996) 0.85
Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus. J Immunol (1983) 0.84
Genetic diversity of the Junin virus in Argentina: geographic and temporal patterns. Virology (2000) 0.80
Analysis of CNS inflammatory responses to MHV. Role of spike determinants in initiating chemokine and cytokine responses. Adv Exp Med Biol (2001) 0.79
Experimental models of virus attenuation and demyelinating disease. Microbiol Sci (1986) 0.79
Dissemination of MHV4 (strain JHM) infection does not require specific coronavirus receptors. Adv Exp Med Biol (1993) 0.79
Molecular and topographic analysis of the glycoproteins of lymphocytic choriomeningitis virus. Med Microbiol Immunol (1986) 0.78
RNA sequence analysis of the E2 genes of wildtype and neuroattenuated mutants of MHV-4 reveals a hypervariable domain. Adv Exp Med Biol (1990) 0.77
MHVR-independent cell-cell spread of mouse hepatitis virus infection requires neutral pH fusion. Adv Exp Med Biol (1995) 0.77
Monoclonal antibody-selected variants of MHV-4 contain substitutions and deletions in the E2 spike glycoprotein. Adv Exp Med Biol (1990) 0.76
Dissecting the molecular anatomy of persistent infection with lymphocytic choriomeningitis virus. Med Microbiol Immunol (1986) 0.75
Persistent infection of mice with Pichinde virus associated with failure to thrive. Microb Pathog (1995) 0.75
Differential effects of MHV-4 infection of astrocytes and oligodendrocytes in vitro. Adv Exp Med Biol (1987) 0.75
Comparative analysis of the structural polypeptides of Ebola viruses from Sudan and Zaire. J Infect Dis (1983) 0.75